Akira Sugiyama

4PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 07, 2026
Duocarmycin-Bearing Antibody-Mimetic Drug Conjugate Combined With an ATR Inhibitor Results in Complete Tumor Regression in a KPL-4 Xenograft Model.

|Sep 17, 2025
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection.

Hyeongki Park, Naotoshi Nakamura, Sho Miyamoto

|Sep 22, 2022
Nucleic acid-triggered tumoral immunity propagates pH-selective therapeutic antibodies through tumor-driven epitope spreading.

Genta Furuya, Hiroto Katoh, Shinichiro Atsumi

|Sep 19, 2022
Pathological complete remission of relapsed tumor by photo-activating antibody-mimetic drug conjugate treatment.

Yudai Kaneko, Kenzo Yamatsugu, Takefumi Yamashita

Pageof 1

Frequent Collaborators

3 joint publications

Hiroto Katoh

1 joint publications

Yudai Kaneko

1 joint publications

Daisuke Komura

1 joint publications

Nobuyoshi Hiraoka